Business hours

Monday - Friday 8am to 4:30pm
After hours or weekends if required by protocol

Horario de oficina

Lunes - Vienes 8 am a 4.30 pm
Fuera de horario o fines de semana si lo requiere el protocolo


(305) 456-9062


Clinical studies

COVID-19 Booster Vaccine

A randomized, observer-blind, active-controlled Phase 3 study to investigate the safety, immunogenicity, and relative vaccine efficacy of mRNA-1283.222 administered as a booster dose compared with mRNA-1273.222 in participants aged 12 years and older for the prevention of COVID-19.

Age group: From 12 years of age
Gender: Male or Female
Duration: Up to 12 months
Compensation: Up to $1,255

About this study:
The purpose of the NextCove study is to evaluate an investigational bivalent vaccine that may protect people from getting sick if they come into contact with the virus that causes COVID-19
and multiple variants, including the Omicron variant. Moderna will be evaluating this investigational vaccine as a booster dose in children and adults to learn more about how it works in the body.

Who can participate?
Participants must be at least 12 years old and have received a COVID-19 vaccine and at least 1 booster dose of a COVID-19 vaccine. The booster doses are not required for participants younger than 18 years o

Where is the study taking place?
The study is being conducted at our facility in Palmetto Medical Plaza.

Current Clinical Research Study Request

Enter your full legal name

Clinical studies



Monday - Friday 9am to 4:30pm
After hours or weekends if required by protocol

Main Line

(305) 456-9141

24 Hour Phone

786) 214-1433


Palmetto Medical Plaza 7100 West 20th Avenue, Suite 411 Hialeah, FL 33016

Email Us